4Sharma R A, Gescher A J, Steward W P. Curcumin : the story so far[J]. Eur J Cancer, 2005, 41 (13) :1955.
5Shishodia S, Chaturvedi M M, Aggarwal B B. Role of curcumin in cancer therapy[ J]. Curr Probl Cancer, 2007, 31 (d) :243.
6Gao X, Kuo J, Jiang H, et al. Immunomodulatory activity of cureumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxieity, and cytokine production in vitro [ J ]. Biochem Pharmaeol, 2004, 68(1 ) :51.
7Chen A, Xu J, Johnson A C. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the tran- scription factor Egr-1 [ J ]. Oncogene, 2006, 25 (2) :278.
8Aggarwal S, Ichikawa H, Takada Y, et al. Curcumin ( diferu- loylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation [ J ]. Mol Pharmacol, 2006, 69(1) :195.
9Kuttan R, Bhanumathy P, Nirmala K, et al. Potential anticancer activity of turmeric (Curcuma longa) [ J]. Cancer Lett, 1985, 29(2) :197.
10Li L, Aggarwal B B, Shishodia S, et al. Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmeth- ane) is associated with the suppression of proliferation and the in- duction of apoptosis[ J]. Cancer, 2004, 101 (10) :2351.
